Menu
GeneBe

CLN5

CLN5 intracellular trafficking protein

Basic information

Region (hg38): 13:76990659-77019143

Links

ENSG00000102805NCBI:1203OMIM:608102HGNC:2076Uniprot:O75503AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 5 (Strong), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 5 (Definitive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 5 (Strong), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis 5 (Supportive), mode of inheritance: AR
  • neuronal ceroid lipofuscinosis (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ceroid lipofuscinosis, neuronal, 5ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic; Ophthalmologic7133332; 1649978; 9662406; 15965709; 15728307; 17607606; 19309691; 20157158; 25359263

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CLN5 gene.

  • Neuronal ceroid lipofuscinosis (516 variants)
  • Neuronal ceroid lipofuscinosis 5 (202 variants)
  • not provided (126 variants)
  • Inborn genetic diseases (62 variants)
  • not specified (47 variants)
  • Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive (28 variants)
  • CLN5-related condition (3 variants)
  • Pontocerebellar hypoplasia type 2D (1 variants)
  • Abnormality of metabolism/homeostasis (1 variants)
  • Intellectual disability (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CLN5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
129
clinvar
131
missense
1
clinvar
8
clinvar
168
clinvar
3
clinvar
180
nonsense
15
clinvar
19
clinvar
34
start loss
2
clinvar
2
frameshift
25
clinvar
32
clinvar
2
clinvar
59
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
8
clinvar
9
splice region
4
10
1
15
non coding
75
clinvar
87
clinvar
13
clinvar
175
Total 42 67 251 219 13

Highest pathogenic variant AF is 0.0000723

Variants in CLN5

This is a list of pathogenic ClinVar variants found in the CLN5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-76991837-A-G Benign (Jun 14, 2018)670727
13-76991941-G-C not specified Likely benign (Mar 31, 2017)383692
13-76991944-G-A not specified • Neuronal ceroid lipofuscinosis 5 Conflicting classifications of pathogenicity (Feb 23, 2018)515683
13-76991952-A-C Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 29, 2023)554902
13-76991952-A-G Neuronal ceroid lipofuscinosis 5 Uncertain significance (Aug 04, 2017)553182
13-76991953-T-A Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis Conflicting classifications of pathogenicity (Jan 03, 2022)205134
13-76991953-T-C Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases • CLN5-related disorder Conflicting classifications of pathogenicity (Jan 28, 2024)166884
13-76991955-C-T not specified • Neuronal Ceroid-Lipofuscinosis, Dominant/Recessive • Neuronal ceroid lipofuscinosis 5 • Neuronal ceroid lipofuscinosis • Inborn genetic diseases Benign (Feb 01, 2024)128782
13-76991956-G-C not specified Likely benign (Sep 10, 2014)205121
13-76991957-C-G Neuronal ceroid lipofuscinosis Likely benign (Nov 19, 2022)2045537
13-76991958-C-T Neuronal ceroid lipofuscinosis • Neuronal ceroid lipofuscinosis 5 Uncertain significance (Sep 06, 2022)205135
13-76991958-CGGAACCTGCGCTT-C Neuronal ceroid lipofuscinosis Uncertain significance (Mar 11, 2022)2109422
13-76991960-G-A Neuronal ceroid lipofuscinosis Likely benign (Apr 15, 2023)1455299
13-76991961-A-T Neuronal ceroid lipofuscinosis • Inborn genetic diseases Uncertain significance (May 17, 2023)1501450
13-76991965-T-C Uncertain significance (Jan 31, 2019)1304983
13-76991966-G-A Neuronal ceroid lipofuscinosis Likely benign (Mar 27, 2021)1545241
13-76991966-G-C Neuronal ceroid lipofuscinosis Likely benign (Mar 09, 2022)2107977
13-76991967-C-A Neuronal ceroid lipofuscinosis Uncertain significance (Oct 24, 2022)1713862
13-76991968-G-T Neuronal ceroid lipofuscinosis Uncertain significance (Aug 26, 2021)661654
13-76991969-C-A Neuronal ceroid lipofuscinosis Likely benign (Nov 03, 2021)1657505
13-76991969-C-G Neuronal ceroid lipofuscinosis Likely benign (Sep 08, 2023)1612774
13-76991970-T-C Neuronal ceroid lipofuscinosis Likely benign (Apr 12, 2023)3010377
13-76991971-T-C Neuronal ceroid lipofuscinosis Uncertain significance (Sep 27, 2022)2070797
13-76991973-G-C Neuronal ceroid lipofuscinosis • Neuronal ceroid lipofuscinosis 5 • Inborn genetic diseases Conflicting classifications of pathogenicity (Oct 27, 2022)205122
13-76991973-G-T Neuronal ceroid lipofuscinosis Uncertain significance (Oct 31, 2022)193341

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CLN5protein_codingprotein_codingENST00000377453 411858
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.71e-80.4091256990491257480.000195
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.1232262211.020.00001032629
Missense in Polyphen6884.9750.800231029
Synonymous0.6717683.80.9070.00000393784
Loss of Function0.8461417.90.7849.09e-7203

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004980.000498
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.00009240.0000924
European (Non-Finnish)0.0002470.000237
Middle Eastern0.0001630.000163
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a role in influencing the retrograde trafficking of lysosomal sorting receptors SORT1 and IGF2R from the endosomes to the trans-Golgi network by controlling the recruitment of retromer complex to the endosomal membrane. Regulates the localization and activation of RAB7A which is required to recruit the retromer complex to the endosomal membrane (PubMed:22431521). {ECO:0000269|PubMed:22431521}.;
Disease
DISEASE: Ceroid lipofuscinosis, neuronal, 5 (CLN5) [MIM:256731]: A form of neuronal ceroid lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy. The lipopigment patterns observed most often in neuronal ceroid lipofuscinosis type 5 comprise mixed combinations of granular, curvilinear, and fingerprint profiles. {ECO:0000269|PubMed:15728307, ECO:0000269|PubMed:16814585, ECO:0000269|PubMed:17607606, ECO:0000269|PubMed:19309691, ECO:0000269|PubMed:20052765, ECO:0000269|PubMed:21990111, ECO:0000269|PubMed:24038957, ECO:0000269|PubMed:24058541, ECO:0000269|PubMed:26342652, ECO:0000269|PubMed:9662406}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Lysosome - Homo sapiens (human) (Consensus)

Recessive Scores

pRec
0.166

Intolerance Scores

loftool
0.287
rvis_EVS
0.06
rvis_percentile_EVS
58.74

Haploinsufficiency Scores

pHI
0.0943
hipred
N
hipred_score
0.150
ghis
0.491

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.386

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cln5
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;

Gene ontology

Biological process
signal peptide processing;lysosomal lumen acidification;brain development;neurogenesis;protein catabolic process;retrograde transport, endosome to Golgi;neuron maturation;glycosylation;positive regulation of GTP binding
Cellular component
lysosome;lysosomal membrane;endoplasmic reticulum;Golgi apparatus;cytosol;integral component of membrane;perinuclear region of cytoplasm;extracellular exosome
Molecular function
protein binding;mannose binding